Artisan Partners
ODT

Artisan Partners’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Artisan Partners’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-80,889
Closed -$2.63M – 347
2019
Q4 		$2.63M Buy
80,889
+2,100
+3% +$65.1K ﹤0.01% 288
2019
Q3 		$2.05M Buy
78,789
+2,789
+4% +$93.3K ﹤0.01% 278
2019
Q2 		$2.79M Buy
+76,000
New +$1.82M 0.01% 275

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners's ODT Position: Q1 2020 in Review

Artisan Partners sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2020, closing a stake of 80,889 shares — an estimated $2.63M sold.

Artisan Partners first reported a position in ODT in Q2 2019 and held it in 3 quarters. The position peaked at $2.79M in Q2 2019. 78 funds tracked by Wall St. Rank hold ODT as of Q1 2020.

  • Artisan Partners reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Artisan Partners sold 80,889 Odonate Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $2.63M.
  • Artisan Partners first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
  • Artisan Partners's Odonate Therapeutics, Inc. Common Stock position peaked at $2.79M in Q2 2019.
  • 78 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Artisan Partners's 13F filing for Q1 2020, filed 12 May 2020.